During one human trial:
"LGD-4033 was safe, had favorable pharmacokinetic profile, and increased lean body mass even during this short period without change in prostate-specific antigen."*
What this means is that patients who use LGD can see an SIGNIFICANT increase in skeletal muscle mass.
HOWEVER, "follicle-stimulating hormone and free testosterone
showed significant suppression at 1.0-mg dose only."*
"Hormone levels and lipids returned to baseline after treatment discontinuation."* This means if and when LGD is dosed at higher levels, post cycle therapeutic measures should be taken to help assist levels to return back to normal.
*The information here is intended for educational and informational purposes only. THIS PRODUCT IS INTENDED FOR RESEARCH USE ONLY.